Sotac Pharmaceuticals Quarterly Results for Trading Insights
SOTAC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QSept 2024
Sotac Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹28 Cr in Sept 2024 (+3.7% vs Mar 2024, +3.7% vs Sept 2023)
- Net Profit of ₹1 Cr in Sept 2024 (-50.0% vs Mar 2024, +0.0% vs Sept 2023)
- EBITDA of ₹3 Cr in Sept 2024 (+50.0% vs Mar 2024)
- Operating Margin of 8.0% in Sept 2024 (+4.0pp vs Mar 2024)
- Earnings Per Share of ₹0.42 in Sept 2024 (-71.8% vs Mar 2024)
Sotac Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2024 | Mar 2024 | Jun 2024 | Sept 2023 | Mar 2023 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 28 | 27 | 26 | 27 | 18 | 3.7% | 3.7% |
| Net Profit (₹ Cr) | 1 | 2 | 2 | 1 | 1 | - | - |
| EBITDA (₹ Cr) | 3 | 2 | 3 | 2 | 3 | - | - |
| EPS (₹) | 0.42 | 1.49 | 1.32 | 0.58 | 1.58 | - | - |
| Operating Margin (%) | 8.0% | 4.0% | 9.0% | 8.0% | 13.0% | - | - |
Sotac Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Sotac Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Sotac Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Sotac Pharmaceuticals
Additional stock information and data for SOTAC
Revenue Trend (₹ Cr)
Sept 2023
27
Jun 2024
26
Mar 2024
27
Sept 2024
28
Net Profit Trend (₹ Cr)
Sept 2023
1
Jun 2024
2
Mar 2024
2
Sept 2024
1
Operating Margin Trend (%)
Sept 2023
8.0%
Jun 2024
9.0%
Mar 2024
4.0%
Sept 2024
8.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sotac Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores